SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Purple Biotech (PPBT-L) Reports $1.0M Q3 Net Loss; Cash Runway Expected Through Late 2027

Purple Biotech reported a Q3 2026 net loss of $1.0M, versus $1.3M in Q3 2025. Its $5.1M in cash, cash equivalents and short-term deposits at September 30 is expected to fund operations through late 2027, based on current estimates and its operating plan.Material DetailsContext by AI AnalystThis is…

PPBT-L

Related stories